Stock A284620 KAINOS MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Kainos Medicine, Inc.

Equities

A284620

KR7284620002

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2,895 KRW -5.08% Intraday chart for Kainos Medicine, Inc. +7.02% -32.99%
2023 Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index CI
2022 Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index
CI
Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd.
CI
Kainos Medicine, Inc. announced that it expects to receive KRW 2.00000052 billion in funding from SC United Co., Ltd.
CI
Kainos Medicine to Raise over $37 Million via Stock Sale
MT
Kainos Medicine, Inc. announced that it has received KRW 12.49997346 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., and other investors
CI
Kainos Medicine, Inc. announced that it expects to receive KRW 12.49997346 billion in funding
CI
Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine
CI
Kainos Medicine, Inc.(KOSDAQ:A284620) added to S&P Global BMI Index
CI
Emmaus Life Sciences Announces Collaboration with Kainos Medicine for Preclinical Development of Irak4 Inhibitor as Potential Anti-Cancer Drug
CI
FAScinate Therapeutics, Inc. announced that it has received KRW 18.100000475 billion in funding from Kainos Medicine, Inc.
CI
Kainos Medicine, Inc. announced that it has received KRW 20 billion in funding from SC United Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co.,Ltd, Asset Management Arm
CI
Kainos Medicine, Inc. announced that it expects to receive KRW 20 billion in funding from SC United Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co.,Ltd, Asset Management Arm
CI
Kainos Medicine, Inc. completed the acquisition of Hana Financial Eleventh Special Purpose Acquisition Company in a reverse merger transaction.
CI
Kainos Medicine, Inc. agreed to acquire Hana Financial Eleventh Special Purpose Acquisition Company in a reverse merger transaction.
CI
Kainos Medicine, Inc. announced that it has received KRW 3.9999933 billion in funding from NH Investment & Securities Co., Ltd., and another investor
CI
Kainos Medicine, Inc. announced that it expects to receive KRW 3.9999933 billion in funding from NH Investment & Securities Co., Ltd., and another investor
CI
Kainos Medicine, Inc. announced that it has received KRW 2.9999934 billion in funding from DSC Investment Inc.
CI
Kainos Medicine, Inc. announced that it expects to receive KRW 2.9999934 billion in funding from DSC Investment Inc.
CI
Kainos Medicine, Inc. announced that it has received KRW 1.55 billion in funding
CI
Kainos Medicine, Inc. announced that it expects to receive KRW 1.55 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A284620 Stock
  4. News Kainos Medicine, Inc.